scholarly journals Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis

Circulation ◽  
2008 ◽  
Vol 118 (3) ◽  
pp. 258-267 ◽  
Author(s):  
C. von zur Muhlen ◽  
D. von Elverfeldt ◽  
J.A. Moeller ◽  
R.P. Choudhury ◽  
D. Paul ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Contrast Agent ◽  
Resonance Imaging ◽  
Activated Platelets ◽  
In Vivo Detection ◽  
Magnetic Resonance Imaging Contrast ◽  
Imaging Contrast Agent

Fe3O4–ZIF-8 assemblies as pH and glutathione responsive T2–T1 switching magnetic resonance imaging contrast agent for sensitive tumor imaging in vivo

2019 ◽  
Vol 55 (4) ◽  
pp. 478-481 ◽  
Author(s):  
Jiaomin Lin ◽  
Pengyan Xin ◽  
Lu An ◽  
Yanjun Xu ◽  
Cheng Tao ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Contrast Agent ◽  
Tumor Imaging ◽  
Resonance Imaging ◽  
Magnetic Resonance Imaging Contrast ◽  
Imaging Contrast Agent

Fe3O4 nanoparticles were assembled into a zeolitic-imidazole framework to form a pH- and glutathione-responsive T2–T1 switching contrast agent for sensitive tumor imaging.

Melanin-manganese nanoparticles with ultrahigh efficient clearance in vivo for tumor-targeting T1 magnetic resonance imaging contrast agent

2018 ◽  
Vol 6 (1) ◽  
pp. 207-215 ◽  
Author(s):  
Wen Xu ◽  
Jinghua Sun ◽  
Liping Li ◽  
Xiaoyang Peng ◽  
Ruiping Zhang ◽  
...  
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Contrast Agent ◽  
Tumor Targeting ◽  
Resonance Imaging ◽  
Agent Based ◽  
Magnetic Resonance Imaging Contrast ◽  
Imaging Contrast Agent ◽  
Manganese Nanoparticles

A magnetic resonance imaging contrast agent, based on Mn2+-chelating melanin nanoparticles, that has ultrahigh efficient clearance in vivo for tumor-targeted imaging.

Sign in / Sign up

Export Citation Format

Share Document